Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy

被引:10
|
作者
Gross, Jeffrey G. [1 ]
Glassman, Adam R. [2 ]
Klein, Margaret J. [2 ]
Jampol, Lee M. [3 ]
Ferris, Frederick L., III [4 ]
Bressler, Neil M. [5 ]
Beck, Roy W. [2 ]
机构
[1] Carolina Retina Ctr, PA Columbia, SC USA
[2] Jaeb Ctr Hlth Res, 15310 Amberly Dr,Ste 350, Tampa, FL 33647 USA
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[4] NEI, NIH, Bethesda, MD 20892 USA
[5] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1001/jamaophthalmol.2017.0969
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:672 / 673
页数:2
相关论文
共 50 条
  • [1] Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
    Bressler, Neil M.
    Beck, Roy W.
    Ferris, Frederick L., III
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (16): : 1520 - 1526
  • [2] Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
    Palanker, Daniel
    Blumenkranz, Mark S.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (04) : 780 - 781
  • [3] Sequence effect in the treatment of proliferative diabetic retinopathy with intravitreal ranibizumab and panretinal photocoagulation
    Cao, Guofan
    Xu, Xiangzhong
    Wang, Chenghu
    Zhang, Shu
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (01) : 34 - 39
  • [4] Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy
    Lin, James
    Chang, Jonathan S.
    Smiddy, William E.
    OPHTHALMOLOGY, 2016, 123 (09) : 1912 - 1918
  • [5] Outcomes of panretinal photocoagulation in proliferative diabetic retinopathy
    Kaiser, RS
    Grunwald, JE
    Maguire, MG
    Lieb, D
    Jani, B
    Brucker, AJ
    Maguire, AM
    Ho, AC
    Fine, SL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 1627 - 1627
  • [6] ETDRS panretinal photocoagulation combined with intravitreal ranibizumab versus PASCAL panretinal photocoagulation with intravitreal ranibizumab versus intravitreal ranibizumab alone for the treatment of proliferative diabetic retinopathy
    Barroso, Rafael de Montier P.
    Messias, Katharina
    Garcia, Denny Marcos
    Cardillo, Jose Augusto
    Scott, Ingrid U.
    Messias, Andre
    Jorge, Rodrigo
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2020, 83 (06) : 526 - 534
  • [7] Panretinal Photocoagulation for Proliferative Diabetic Retinopathy REPLY
    Chappelow, Aimee V.
    Tan, Kevin
    Kaiser, Peter K.
    Waheed, Nadia K.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (04) : 781 - 781
  • [8] Efficacy and safety of ranibizumab with or without panretinal laser photocoagulation versus laser photocoagulation alone in proliferative diabetic retinopathy - the PRIDE study
    Lang, Gabriele E.
    Stahl, Andreas
    Voegeler, Jessica
    Quiering, Claudia
    Lorenz, Katrin
    Spital, Georg
    Liakopoulos, Sandra
    ACTA OPHTHALMOLOGICA, 2020, 98 (05) : E530 - E539
  • [9] Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy A Randomized Clinical Trial
    Gross, Jeffrey G.
    Glassman, Adam R.
    Jampol, Lee M.
    Inusah, Seidu
    Aiello, Lloyd Paul
    Antoszyk, Andrew N.
    Baker, Carl W.
    Berger, Brian B.
    Bressler, Neil M.
    Browning, David
    Elman, Michael J.
    Ferris, Frederick L., III
    Friedman, Scott M.
    Marcus, Dennis M.
    Melia, Michele
    Stockdale, Cynthia R.
    Sun, Jennifer K.
    Beck, Roy W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (20): : 2137 - 2146
  • [10] Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab
    Bressler, Susan B.
    Beaulieu, Wesley T.
    Glassman, Adam R.
    Gross, Jeffrey G.
    Jampol, Lee M.
    Melia, Michele
    Peters, Mark A.
    Rauser, Michael E.
    OPHTHALMOLOGY, 2017, 124 (04) : 431 - 439